Clinical Trials Sponsored by LumiraDx

Total 18 results

LumiraDx UK Limited

Suspended

Sample Collection Study to Aid Evaluation of an Influenza A/B, Respiratory Syncytial Virus & COVID-19 Virus POC Test (INFORM)

Covid19 | RSV Infection | Influenza Type B | Influenza Type A

United Kingdom
LumiraDx UK Limited

Active, not recruiting

Evaluation of the LumiraDx Point of Care D-Dimer and CRP Tests (NOVEL-3)

Inflammation | Embolism and Thrombosis | Infection

United States
LumiraDx UK Limited

Completed

Performance Evaluation of the LumiraDx SARS-CoV-2 & FLU A/B and SARS-CoV-2 & RSV Tests for Aid in the Assessment of COVID-19 (INSPIRE-2)

COVID-19 | Influenza A | RSV Infection | Influenza Type B

United States
LumiraDx UK Limited

Suspended

Performance Evaluation of the LumiraDX SARS-CoV-2 Ag Ultra and LumiraDX SARS-CoV-2 & Flu A/B Tests at Point of Care (POC) Sites (PURSUE)

COVID-19 | SARS-CoV-2 | Influenza A | Influenza B

United States
LumiraDx UK Limited

Active, not recruiting

Performance Evaluation of LumiraDx COVID-19 (SARS-CoV-2) Ag Test (ASPIRE)

Covid19

United States
LumiraDx UK Limited

Active, not recruiting

Performance Evaluation of LumiraDx COVID-19 (SARS-CoV-2) Ag ULTRA Test (ASPIRE-2) (ASPIRE-2)

COVID-19

United States
LumiraDx UK Limited

Active, not recruiting

Research & Evaluation of LumiraDx SARS-CoV-2 (COVID-19) Point of Care Ab Test (CAPTURE-2)

Covid19

United States
LumiraDx UK Limited

Not yet recruiting

Clinical Validation of the LumiraDx SARS-CoV-2 & Flu A/B Test in Detecting and Differentiating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Influenza A (Flu A), and/or Influenza B (Flu B)

SARS-CoV-2 | Influenza A | Asymptomatic COVID-19 | Influenza B

United States
LumiraDx UK Limited

Recruiting

Collection of Blood Samples for New Diagnostic Devices 2 (NOVEL-2)

Infections | Inflammation | Embolism and Thrombosis | Cardiovascular | Renal

United Kingdom
LumiraDx UK Limited

Recruiting

Evaluation of Performance of the LumiraDx Influenza A/B + RSV Test at POC Testing Sites (INSPIRE)

Influenza, Human | Respiratory Syncytial Virus Infections

United States
LumiraDx UK Limited

Completed

A Performance Evaluation of the Lumiradx Point of Care HbA1c Device (PHADE)

Diabetes

United Kingdom
LumiraDx UK Limited

Suspended

COVID-19: A POC Test Under Research & Evaluation (CAPTURE)

COVID-19

United Kingdom
LumiraDx UK Limited

Completed

A Performance Evaluation of the LumiraDx Point of Care CRP Assay (REACT)

Infections | Inflammation | Tissue Injury

United Kingdom
LumiraDx UK Limited

Active, not recruiting

A Performance Evaluation of the LumiraDx Point Of Care D-dimer Assay (EMBOL1)

Deep Vein Thrombosis | Venous Thromboembolism | Pulmonary Embolism

United Kingdom, Germany
LumiraDx UK Limited

Completed

Evaluation of the Accuracy of INR Results From Patients Taking Phenprocoumon as Anticoagulant When Measured Using the Lumiradx INR Test (VKA GERMANY)

Anticoagulants and Bleeding Disorders

Germany
LumiraDx UK Limited

Completed

Evaluation of Precision and Accuracy of INR Measurements in a Point of Care Device (OPTIMAL) (OPTIMAL)

Atrial Fibrillation | Thrombophilia | Deep Vein Thrombosis | Antiphospholipid Syndrome | Pulmonary Embolism | Post-Myocardial Infarction Syndrome | Artificial Heart Device User

United Kingdom
Jonsson Comprehensive Cancer Center
MiraDX

Active, not recruiting

Germline DNA-Based Radiosensitivity Biomarker Influence on Toxicity Following Prostate Radiotherapy, GARUDA Trial (GARUDA)

Prostate Adenocarcinoma | Stage II Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage IIA Prostate Cancer AJCC v8 | Stage IIB Prostate Cancer AJCC v8 | Stage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8

United States
Manchester University NHS Foundation Trust
National Institute for Health Research, United Kingdom; Roche Diagnostics; Abbott... and other collaborators

Active, not recruiting

The Pre-hospital Evaluation of Sensitive Troponin (PRESTO) Study

Chest Pain | Acute Coronary Syndrome | Heart Attack

United Kingdom

Clinical Trials Sponsored by LumiraDx

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Finland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations